<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>PMC</source>
  <date>20140719</date>
  <key>pmc.key</key>
  <document>
    <id>5007554</id>
    <passage>
      <infon key="name_2">surname:Hrdinka;given-names:Matous</infon>
      <infon key="name_3">surname:Lopez&#8208;Rojas;given-names:Jeffrey</infon>
      <infon key="name_0">surname:Kravchick;given-names:Dana O</infon>
      <infon key="name_1">surname:Karpova;given-names:Anna</infon>
      <infon key="name_6">surname:Iacobas;given-names:Dumitru A</infon>
      <infon key="alt-title">Dana O Kravchick et&#160;al</infon>
      <infon key="article-id_publisher-id">EMBJ201593070</infon>
      <infon key="name_5">surname:Carbonell;given-names:Abigail U</infon>
      <infon key="name_8">surname:Jordan;given-names:Bryen A</infon>
      <infon key="lpage">1934 1934</infon>
      <infon key="fpage">1923 1923</infon>
      <infon key="year">2016</infon>
      <infon key="name_7">surname:Kreutz;given-names:Michael R</infon>
      <infon key="name_4">surname:Iacobas;given-names:Sanda</infon>
      <infon key="title">Subject Categories</infon>
      <infon key="article-id_doi">10.15252/embj.201593070</infon>
      <infon key="article-id_pmid">27458189</infon>
      <infon key="source">The EMBO Journal</infon>
      <infon key="issue">17</infon>
      <infon key="kwd">FBW7 immediate early gene ischemia photoactivation synapse to nucleus Neuroscience</infon>
      <infon key="volume">35 35</infon>
      <infon key="pub-id_pmid">27458189</infon>
      <infon key="article-id_pmc"/>
      <infon key="type">front</infon>
      <infon key="notes"> () : &#8211;</infon>
      <offset>0</offset>
      <text>Synaptonuclear messenger PRR7 inhibits c&#8208;Jun ubiquitination and regulates NMDA&#8208;mediated excitotoxicity</text>
    </passage>
    <passage>
      <infon key="type">abstract_title_1</infon>
      <offset>107</offset>
      <text>Abstract</text>
    </passage>
    <passage>
      <infon key="type">abstract</infon>
      <offset>116</offset>
      <text>Elevated c&#8208;Jun levels result in apoptosis and are evident in neurodegenerative disorders such as Alzheimer's disease and dementia and after global cerebral insults including stroke and epilepsy. NMDA receptor (NMDAR) antagonists block c&#8208;Jun upregulation and prevent neuronal cell death following excitotoxic insults. However, the molecular mechanisms regulating c&#8208;Jun abundance in neurons are poorly understood. Here, we show that the synaptic component Proline rich 7 (PRR7) accumulates in the nucleus of hippocampal neurons following NMDAR activity. We find that PRR7 inhibits the ubiquitination of c&#8208;Jun by E3 ligase SCFFBW7 (FBW7), increases c&#8208;Jun&#8208;dependent transcriptional activity, and promotes neuronal death. Microarray assays show that PRR7 abundance is directly correlated with transcripts associated with cellular viability. Moreover, PRR7 knockdown attenuates NMDAR&#8208;mediated excitotoxicity in neuronal cultures in a c&#8208;Jun&#8208;dependent manner. Our results show that PRR7 links NMDAR activity to c&#8208;Jun function and provide new insights into the molecular processes that underlie NMDAR&#8208;dependent excitotoxicity.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>1256</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>1269</offset>
      <text>The transcription factor c&#8208;Jun is a principal component of the activator protein 1 (AP&#8208;1) complex, which is involved in the immediate early response following neuronal activity (Raivich &amp; Behrens, 2006). To form the AP&#8208;1 complex, c&#8208;Jun can homo&#8208; or heterodimerize with members of the Fos or ATF families of transcription factors. AP&#8208;1 is required for neuronal survival and synaptic plasticity, and has been implicated in seizures, addiction, pain, and posttraumatic repair in the CNS (Alberini, 2009). Despite considerable interest in AP&#8208;1 biology, relatively little is known about how neuronal activity regulates c&#8208;Jun protein levels (Cruzalegui et&#160;al, 1999; Tischmeyer &amp; Grimm, 1999). NMDAR activity increases c&#8208;Jun abundance in several neurodegenerative disorders and following ischemia or status epilepticus (Dragunow et&#160;al, 1993; Herdegen et&#160;al, 1997; Zhang et&#160;al, 2006). In the retina, excitotoxic NMDAR stimulation upregulates c&#8208;Jun mRNA and protein abundance (Munemasa et&#160;al, 2006) and triggers c&#8208;Jun phosphorylation at amino acid residues 63/73 by activating c&#8208;Jun N&#8208;terminal kinases (JNK) (Yang et&#160;al, 1997; Coffey, 2014). Phosphorylated c&#8208;Jun is transcriptionally active and can induce apoptosis via upregulation of cell death&#8208;inducing genes (Ham et&#160;al, 1995; Behrens et&#160;al, 1999; Song et&#160;al, 2011) or by downregulating anti&#8208;apoptotic genes through repressor activity (Shaulian &amp; Karin, 2002; Miao &amp; Ding, 2003). Although numerous studies implicate c&#8208;Jun in apoptosis, its cellular function is context and stimulus dependent (Leppa &amp; Bohmann, 1999) as c&#8208;Jun can also regulate axon regeneration and synaptic plasticity (Alberini, 2009; Hu et&#160;al, 2015).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>2978</offset>
      <text>In neurons, c&#8208;Jun protein levels are kept low by rapid proteasomal&#8208;mediated degradation to prevent cellular apoptosis (Nateri et&#160;al, 2004). The HECT&#8208;type E3&#8208;ligase Itch (Fang et&#160;al, 2002), MEKK1 (Xia et&#160;al, 2007), and RING type E3 ligase SCFFBW7 complex (composed of Skp1, Cullin1, and the F&#8208;box protein FBW7) (Nateri et&#160;al, 2004) can ubiquitinate and promote c&#8208;Jun proteasomal degradation. Ubiquitination by FBW7 requires c&#8208;Jun phosphorylation at Ser63/73 and Thr91/93. NMDAR stimulation increases c&#8208;Jun phosphorylation and transcriptional activity by activating JNK (Schwarzschild et&#160;al, 1997). While MAPK&#8208;dependent phosphorylation can stabilize c&#8208;Jun expression in 3T3 cells (Musti et&#160;al, 1997), factors that protect c&#8208;Jun from polyubiquitination and degradation in neurons are unknown.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>3796</offset>
      <text>Several groups, including our own, identified PRR7 in mass spectrometry&#8208;based screens of postsynaptic densities (PSD) from rodent brains (Jordan et&#160;al, 2004; Yoshimura et&#160;al, 2004; Murata et&#160;al, 2005). PRR7 was found to interact with the membrane&#8208;associated guanylate kinase PSD95 via its C&#8208;terminal PDZ ligand and associate with the NMDAR complex (Murata et&#160;al, 2005). PRR7 structure resembles that of transmembrane adaptor proteins (TRAPs) (Hrdinka et&#160;al, 2011), which mediate T&#8208;cell receptor signaling by assembling a membrane proximal signalosome. In Jurkat T cells, the expression of PRR7 triggers apoptotic cell death that is preceded by c&#8208;Jun upregulation, suggesting that PRR7 might regulate T&#8208;cell survival in a manner that involves c&#8208;Jun (Hrdinka et&#160;al, 2011).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>4587</offset>
      <text>Here, we show that NMDAR stimulation increases PRR7 levels in the nucleus and that PRR7 inhibits FBW7&#8208;mediated c&#8208;Jun ubiquitination. We propose that PRR7 is a neuronal FBW7 inhibitor and a novel nuclear signaling molecule linking NMDAR activity to c&#8208;Jun function. Moreover, we propose that PRR7 mediates NMDAR&#8208;mediated excitotoxicity in neuronal cultures in a c&#8208;Jun&#8208;dependent manner.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>4983</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>4991</offset>
      <text>PRR7 expression and subcellular distribution in brain</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>5045</offset>
      <text>Little is known about PRR7 expression in brain, so we first determined its tissue and developmental distribution. We found that PRR7 was highly expressed in rat forebrain (Appendix&#160;Fig S1A) and showed strong developmental regulation, with expression evident at postnatal day 7 and plateauing ~4&#160;weeks after birth (Appendix&#160;Fig S1B). This was similar to the developmental profiles of the NMDAR subunit GluN1 and PSD95, which correlates with synaptogenesis in rodent brains. Immunocytochemistry of rat primary hippocampal cultures at DIV21 showed that endogenous PRR7 had a punctate distribution throughout synaptodendritic compartments and colocalized with synaptic markers (Fig&#160;1A&#8211;C and Appendix&#160;Fig S1C). To determine the extent of synaptic colocalization, we performed triple colocalization analysis between PRR7, Bassoon, and PSD95 (Fig&#160;1B) and found that 38.8&#160;&#177;&#160;3.6% (n&#160;=&#160;9 neurons, P&#8208;value&#160;&lt;&#160;0.0001) of bona fide synapses (containing both PSD95 and Bassoon) contained PRR7. This suggests that PRR7 is abundant in some, but not all synaptic junctions. Exogenously expressed GFP&#8208;tagged PRR7 also colocalized with the synaptic marker Bassoon, corroborating imaging results of endogenous PRR7 distribution (Fig&#160;1C). PRR7 was also present in the soma and showed variable expression in the nucleus (Fig&#160;1A, lower panels). Quantitation of PRR7 abundance throughout the neuron showed enriched, but significantly variable expression in nuclear and synaptic regions compared to perinuclear and dendritic regions (Appendix&#160;Fig S1C). Western blot analysis of subcellular fractions isolated from rat brains showed that PRR7 was markedly enriched in the PSD fraction, but was also present in purified nuclear fractions (Fig&#160;1D).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>6788</offset>
      <text>Synaptic and nuclear localization of PRR7</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>6830</offset>
      <text>Upper panels: Immunofluorescence imaging of PRR7 with Shank (synaptic) and MAP2 (dendritic) markers in DIV21 hippocampal neurons. Lower panels: single&#8208;plane Apotome images of nuclei (DAPI) show PRR7 can be present (arrow) or absent (arrowhead) from nuclei. Scale bar is 15&#160;&#956;m.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7111</offset>
      <text>Synaptic and dendritic distribution of PRR7 and pre (Bassoon)&#8208; and postsynaptic (PSD95) markers (arrowheads, triple colocalization).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7246</offset>
      <text>PRR7&#8208;GFP expressed in 17DIV hippocampal neurons is present in dendritic spines (arrows). Scale bar is 15&#160;&#956;m.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7359</offset>
      <text>PRR7 distribution across subcellular fractions (TOT&#160;=&#160;whole lysate, Syn&#160;=&#160;synaptosomes, Nuc&#160;=&#160;nuclei) isolated from rat hippocampal tissue. Fib (fibrillarin), SNAP25, and PSD95 were used as nuclear, presynaptic, and postsynaptic markers, respectively.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7617</offset>
      <text>Source data are available online for this figure.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>7667</offset>
      <text>NMDAR activation elevates PRR7 expression in the nucleus</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>7724</offset>
      <text>PRR7 contains a putative lysine and arginine rich nuclear localization sequence (NLS) (KRR&#8208;RLR) near the N&#8208;terminus. Given immunocytochemical (Fig&#160;1A and Appendix&#160;Fig S1C) and Western blot (Fig&#160;1D) evidence of both synaptic and nuclear PRR7, we determined whether neuronal activity regulated the subcellular distribution of PRR7. Glutamate stimulation of rat DIV 21 primary hippocampal cultures increased PRR7 abundance in the nucleus (Fig&#160;2A). This increase was also evident in the presence of the protein synthesis inhibitor cycloheximide, suggesting that it was not mediated by increased protein translation. We also noted that glutamate stimulation led to elevated levels of PRR7 in the soma (Fig&#160;2A). However, the increase in nuclear PRR7 was larger than the increase in somatic PRR7 as measured by an elevated ratio of nuclear to cytoplasmic PRR7 following stimulation (Appendix&#160;Fig S2D). These results are consistent with an activity&#8208;dependent nuclear import. Glutamate stimulation also led to a concomitant reduction of PRR7 abundance at synapses that was not inhibited by the proteasome inhibitor epoxomicin (Fig&#160;2B), suggesting that the decrease was not mediated by proteasomal degradation. To corroborate these results using another method, we treated high&#8208;density cortical cultures with glutamate and purified both synaptic and nuclear fractions from harvested cells (Appendix&#160;Fig S2A). As expected, glutamate stimulation led to an increase of PRR7 in the nucleus (Appendix&#160;Fig S2B) with a concomitant decrease at synapses (Appendix&#160;Fig S2C). To identify the specific ionotropic receptor activity required for this translocation, we treated neurons with glutamate in the presence of the NMDAR antagonist APV or the AMPAR antagonist CNQX. Only APV blocked the increase in nuclear PRR7 (Fig&#160;2C). Neither CNQX nor the voltage&#8208;gated sodium channel blocker tetrodotoxin (TTX) blocked this process, suggesting that the accumulation of PRR7 in the nucleus did not require action potentials.</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>9741</offset>
      <text>NMDAR activation regulates PRR7 subcellular distribution</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>9798</offset>
      <text>Immunocytochemical analyses show that glutamate stimulation (Glut, 100&#160;&#956;M 5&#160;min&#160;+&#160;25&#160;min washout) increased PRR7 in the nucleus. Cycloheximide (100&#160;&#956;M) added 30&#160;min prior to glutamate stimulation did not affect this increase (Cont&#160;=&#160;100&#160;&#177;&#160;12.5%, Glut&#160;=&#160;202.1&#160;&#177;&#160;15.2%; +cycloheximide Cont&#160;=&#160;104.9&#160;&#177;&#160;3.6, Glut&#160;=&#160;231.4&#160;&#177;&#160;10.9) (n&#160;=&#160;&#732;30&#8211;50 cells). Values are presented as mean&#160;&#177;&#160;s.e.m. Statistical analysis was performed using the Mann&#8211;Whitney test. ***P&#160;&lt;&#160;0.001.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>10299</offset>
      <text>Decreased synaptic PRR7 immunostaining following glutamate stimulation in DIV 21 hippocampal neurons. Epoxomicin (50&#160;nM) added 20&#160;min prior to stimulation did not affect this decrease (Cont&#160;=&#160;100&#160;&#177;&#160;3.6%, Glut&#160;=&#160;32.3&#160;&#177;&#160;1.3%; +epoxomicin Cont&#160;=&#160;99.8&#160;&#177;&#160;4.6, Glut&#160;=&#160;42.9&#160;&#177;&#160;1.1) (n&#160;=&#160;14&#8211;17 dendrites, &gt;&#160;1,200 puncta for each group). Values are presented as mean&#160;&#177;&#160;s.e.m. Statistical analysis was performed using the Mann&#8211;Whitney test. ***P&#160;&lt;&#160;0.001.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>10777</offset>
      <text>Quantification of nuclear PRR7 immunostaining in cultured hippocampal neurons. Treatments (APV [50&#160;&#956;M, APV&#8208;(2R)&#8208;amino&#8208;5&#8208;phosphonovaleric acid], CNQX [40&#160;&#956;M, 6&#8208;cyano&#8208;7 nitroquinoxaline&#8208;2,3&#8208;dione], TTX [1&#160;&#956;M, tetrodotoxin], NMDA [50&#160;&#956;M, N&#8208;methyl&#8208;D&#8208;aspartate]) as indicated. Only APV treatment blocked the glutamate&#8208;dependent increase in nuclear PRR7 (108.1&#160;&#177;&#160;19%). Values are presented as mean&#160;&#177;&#160;s.e.m. Statistical significance was determined using one&#8208;way ANOVA in conjugation with Sidak post hoc test. (n&#160;=&#160;&#8764;30&#8211;50 cells from 3 independent experiments) *P&#160;&lt;&#160;0.05, ***P&#160;&lt;&#160;0.001, ****P&#160;&lt;&#160;0.0001.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>11422</offset>
      <text>PRR7&#8208;GFP accumulates in the nucleus of hippocampal neurons upon NMDA treatment. Depicted are representative averaged confocal images (30&#160;&#215;&#160;30&#160;&#956;m2) from optical sections (300&#160;nm step size) of PRR7&#8208;GFP&#8208;expressing neurons (DIV17) before and after bleaching. Prior to stimulation, there was substantial PRR7&#8208;GFP in the nucleus due to basal neuronal activity (upper panel). This was reduced by incubation overnight with MK801 (10&#160;&#956;M) and TTX (1&#160;&#956;M) (lower&#160;panel). NMDA (50&#160;&#956;M) stimulation, but not MK&#8208;801, led to recovery of nuclear PRR7&#8208;GFP fluorescence following bleaching of nuclear ROIs at t0&#8242; (blue arrow in E). Scale bar is 15&#160;&#956;m.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>12083</offset>
      <text>Quantification of changes in nuclear GFP fluorescent intensities was normalized to time point t0&#8242; and corrected for bleaching. No significant differences in PRR7&#8208;GFP FRAP were found in control (MK801) conditions. GFP intensities are displayed via look&#8208;up table (LUT). Data are represented as mean&#160;&#177;&#160;s.e.m.; n&#160;=&#160;9 cells (NMDA) and n&#160;=&#160;5 cells (MK801). Analysis was done using one&#8208;way ANOVA using Bonferroni post hoc correction. ***P&#160;&lt;&#160;0.001.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>12541</offset>
      <text>PRR7&#8208;mEos translocates from distal dendrites to the nucleus upon NMDA treatment. (Left panels) Confocal maximal intensity projection images of hippocampal neurons expressing PRR7&#8208;mEos before and after photoconversion of distal dendrites (ROIs) through the image z&#8208;stack from green (488&#160;nm) to red (568&#160;nm) using a UV laser (405&#160;nm). (Right panels) Averaged intensity projection images from nuclear planes showing accumulation of photoconverted PRR7&#8208;mEos (568&#160;nm) in the nucleus following NMDA stimulation (50&#160;&#956;M, 30&#160;min). Scale bar is 15&#160;&#956;m.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>13100</offset>
      <text>Paired quantification of changes in background corrected fluorescent intensities of nuclear PRR7&#8208;mEos at 0&#160;min and 30&#160;min following NMDA stimulation or MK801 treatment (Average increase; NMDA&#160;=&#160;617.8&#160;&#177;&#160;47.7%, n&#160;=&#160;11 cells, P&#160;&lt;&#160;0.0005; MK801&#160;=&#160;206.1&#160;&#177;&#160;13.6%, n&#160;=&#160;5 cells, n.s.). Values are presented as mean&#160;&#177;&#160;s.e.m. Statistical significance was determined by two&#8208;way ANOVA using Sidak's correction for multiple comparisons. ***P&#160;&lt;&#160;0.001, ****P&#160;&lt;&#160;0.0001.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>13583</offset>
      <text>To assess the dynamics of PRR7 redistribution, we used fluorescence recovery after photobleaching (FRAP) to track the nuclear accumulation of PRR7&#8208;GFP following NMDAR stimulation. PRR7&#8208;GFP was already present in the nucleus of non&#8208;stimulated cells with basal synaptic activity but was also prominently localized in dendrites and the soma (Figs&#160;1C and 2D). We observed a rapid recovery of GFP fluorescence in photobleached nuclei in response to bath application of NMDA, indicating an activity&#8208;dependent nuclear import of PRR7 (Fig&#160;2D and E). This import was not visible when we applied the NMDAR antagonist MK801 overnight and during stimulation (Fig&#160;2D and E). Treatment with MK801 significantly decreased basal PRR7&#8208;GFP fluorescence in the nucleus and soma (Fig&#160;2D).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>14366</offset>
      <text>To confirm that PRR7 was translocating from distal dendrites into the nucleus, we transfected neurons with a PRR7 construct fused to the photoconvertible fluorescent protein mEos3 (Zhang et&#160;al, 2012b). Following expression of the fusion protein, we photoconverted PRR7&#8208;mEos in distal dendritic regions (ROIs) from green to red fluorescence and monitored accumulation of red&#8208;PRR7&#8208;mEos in the nucleus 30&#160;min after stimulation with 50&#160;&#956;M NMDA (Fig&#160;2F and G). We found a robust increase in red&#8208;PRR7&#8208;mEos in the nucleus following treatment with NMDA, but not with MK801 (Fig&#160;2F and G). These results, together with FRAP experiments and imaging and biochemical analyses of endogenous PRR7, strongly suggest that PRR7 translocates from synapses to nuclei following NMDAR activity.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>15156</offset>
      <text>PRR7 interacts with NMDARs in rat brain</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>15196</offset>
      <text>Several activity&#8208;dependent synapse&#8208;to&#8208;nucleus messengers bind to NMDARs (Jordan &amp; Kreutz, 2009). We confirmed that PRR7 interacts with PSD95 and NMDARs in adult mouse brains (Murata et&#160;al, 2005) using co&#8208;immunoprecipitation experiments (Fig&#160;3A). As PRR7 and NMDAR bind to different PDZ domains of PSD95 (Niethammer et&#160;al, 1996; Murata et&#160;al, 2005), we hypothesized that they might associate indirectly via PSD95. To clarify this, we first co&#8208;expressed GluN1 and a PRR7 construct with a C&#8208;terminal myc&#8208;tag blocking the PDZ ligand in HEK293 cells, which lack PSD95. However, PRR7 bound to GluN1 despite the blocked PDZ ligand, suggesting that PSD95 was not required (Fig&#160;3B). This interaction was specific as PRR7 did not bind to the AMPAR subunits GluA1 or GluA2 (Fig&#160;3C) and did not require the GluN2A or GluN2B subunits of NMDARs (Fig&#160;3B). Binding to NMDARs was preserved under stringent conditions (RIPA buffer) and required the transmembrane domain (TM), the short N&#8208;terminus, and 15 amino acids of the intracellular domain of PRR7 (Fig&#160;3D).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>16265</offset>
      <text>PRR7 binding to GluN1 is regulated by NMDAR activity</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>16318</offset>
      <text>Co&#8208;Immunoprecipitations (Co&#8208;IPs) of PRR7 with GluN1, PSD95 and GluN2B from rat brain lysates. FT&#160;=&#160;flowthrough, IgG&#160;=&#160;normal IgGs.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>16457</offset>
      <text>Co&#8208;IPs from HEK293 cells of C&#8208;terminal myc&#8208;tagged PRR7 with GluN1 in the absence of other NMDAR subunits or PSD95.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>16578</offset>
      <text>Co&#8208;IPs from HEK293 cells transfected with tagged NMDA or AMPA receptor subunits and PRR7 (myc&#8208;tagged GluN2B and GluA2 and flag&#8208;tagged PRR7).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>16725</offset>
      <text>(Top) Schematics of the different PRR7 constructs used for co&#8208;IP (FL&#160;=&#160;full length). (Bottom) PRR7 deletion constructs and NMDAR subunits were expressed in HEK293 cells and Co&#8208;IPs performed as indicated.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>16935</offset>
      <text>Co&#8208;IPs of PRR7 with GluN1 from high&#8208;density primary neuronal cultures following treatment with NMDA (100&#160;&#956;M, 30&#160;min, representative of n&#160;=&#160;4).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>17087</offset>
      <text>Source data are available online for this figure.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>17137</offset>
      <text>We next asked whether PRR7 might have any effect on NMDA&#8208;mediated currents in HEK cells (Appendix&#160;Fig S3A and B) or in primary hippocampal neurons (Appendix&#160;Fig S3C). We found that PRR7 had no effect on NMDAR currents when co&#8208;expressed with NMDAR subunits in HEK cells (Appendix&#160;Fig S3A and B), irrespective of expressing GluN1 with GluN2A (Appendix&#160;Fig S3A) or GluN2B (Appendix&#160;Fig S3B). Moreover, shRNA&#8208;mediated knockdown of PRR7 had no effects on NMDA currents in primary hippocampal neurons (Appendix&#160;Fig S3C). We also assessed possible effects of PRR7 on miniature AMPAR&#8208;mediated currents. However, overexpression of PRR7 in cultured neurons modified neither amplitude nor frequency of AMPAR&#8208;mediated currents (Appendix&#160;Fig S3E and F). Collectively, these data do not support a role for PRR7 in regulating synaptic function.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>17984</offset>
      <text>As NMDAR activation resulted in an accumulation of PRR7 in the nucleus (Fig&#160;2), we hypothesized that the interaction of PRR7 with GluN1 was modulated by NMDAR activity. We treated hippocampal cultured neurons with NMDA and found that this reduced the extent of PRR7&#8208;GluN1 interactions (Fig&#160;3E). Together, our results suggest that PRR7 associates with GluN1 independent of PSD95 and dissociates from NMDARs following neuronal activity to allow for nuclear import.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>18451</offset>
      <text>PRR7 inhibits c&#8208;Jun ubiquitination</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>18488</offset>
      <text>As PRR7 was shown to regulate c&#8208;Jun expression and phosphorylation (Hrdinka et&#160;al, 2011), we hypothesized that PRR7 could link NMDAR activity to c&#8208;Jun function. Therefore, we generated lentiviruses to knockdown (shRNAs) or overexpress PRR7 in primary neuronal cultures and found that PRR7 and c&#8208;Jun abundance were directly correlated. PRR7 knockdown decreased c&#8208;Jun abundance, while PRR7 overexpression increased c&#8208;Jun abundance (Fig&#160;4A). Neither overexpression nor knockdown of PRR7 altered c&#8208;Fos abundance (Fig&#160;4A). In HEK293 cells treated with cycloheximide, we found that PRR7 expression significantly increased c&#8208;Jun half&#8208;life (Fig&#160;4B), suggesting that PRR7 inhibits c&#8208;Jun degradation. PRR7 contains a putative phosphodegron motif (VTPFLS) at amino acid 175, suggesting it may interact with the E3 ubiquitin ligase FBW7, which has been shown to ubiquitinate c&#8208;Jun in neurons (Nateri et&#160;al, 2004). To determine whether PRR7 regulated c&#8208;Jun ubiquitination, we expressed FBW7 in HEK293 cells in the presence or absence of PRR7 and performed ubiquitination pulldown assays. We chose HEK293 cells because they do not express PRR7, have low amounts of FBW7, and express high amounts of c&#8208;Jun. We confirmed that FBW7 overexpression increased c&#8208;Jun ubiquitination (Fig&#160;4C) as previously reported (Nateri et&#160;al, 2004). However, co&#8208;expression of FBW7 with PRR7 significantly blocked c&#8208;Jun ubiquitination (Fig&#160;4C). To determine whether PRR7 regulated c&#8208;Jun ubiquitination in neurons, we knocked down PRR7 in hippocampal neuronal cultures using lentiviral shRNAs and found that this led to increased c&#8208;Jun ubiquitination (Fig&#160;4D). These results suggest that PRR7 inhibits c&#8208;Jun ubiquitination in neurons. PRR7 knockdown or overexpression had no effect on other FBW7 targets mTOR and Myc (Davis et&#160;al, 2014) in neurons (Fig&#160;4E), or in HEK293 cells (Appendix&#160;Fig S4). Taken together, these results suggest that PRR7 specifically inhibits c&#8208;Jun ubiquitination and is not a general inhibitor of FBW7.</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>20528</offset>
      <text>PRR7 inhibits c&#8208;Jun ubiquitination</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>20565</offset>
      <text>Western blots of lysates of primary neurons transduced with control lentiviruses (NT) or lentiviruses to knockdown (KD) or overexpress (OE) PRR7. PRR7 knockdown reduced (75.6&#160;&#177;&#160;6.9%) while PRR7 overexpression (OE) increased (157.6&#160;&#177;&#160;22.8%) c&#8208;Jun levels compared to controls. No change was detected in c&#8208;Fos levels. Values are presented as mean&#160;&#177;&#160;s.e.m. **P&#160;&lt;&#160;0.01. One&#8208;way ANOVA test was used to analyze results with Dunett's post hoc test (n&#160;=&#160;16 gels for c&#8208;Jun and 4 gels for c&#8208;Fos).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>21074</offset>
      <text>Control or PRR7&#8208;transfected HEK293 cells were treated with cycloheximide for the indicated time points, and c&#8208;Jun protein levels were measured by Western blotting. PRR7 expression significantly stabilized c&#8208;Jun levels at 120&#160;min (110.0&#160;&#177;&#160;7.5% versus control 68.7&#160;&#177;&#160;7.9%) and 240&#160;min (83.6&#160;&#177;&#160;5.2% versus control 43.7&#160;&#177;&#160;3.4%). Values for c&#8208;Jun were normalized to their respective 0&#160;min time point (n&#160;=&#160;4 gels for each group performed blind). Values are presented as mean&#160;&#177;&#160;s.e.m. t&#8208;tests between similar time points were used to analyze results. **P&#160;&lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>21662</offset>
      <text>PRR7, FBW7, and/or a control protein (PSD95) were transfected into HEK293 cells and c&#8208;Jun ubiquitination was measured by immunoprecipitating c&#8208;Jun and blotting for ubiquitin. Ubiquitination of c&#8208;Jun in the presence of FBW7 (178.3&#160;&#177;&#160;26.9%) was significantly reduced in the presence of PRR7 (103.7&#160;&#177;&#160;20.6%) but not a control protein (PSD95) (n&#160;=&#160;5 gels for all groups). Values are presented as mean&#160;&#177;&#160;s.e.m. Significance was determined using two&#8208;way ANOVA with Dunnett's post hoc test. *P&#160;&lt;&#160;0.05.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>22178</offset>
      <text>Western blots of c&#8208;Jun ubiquitination in hippocampal primary neuronal cultures. PRR7 knockdown (KD) elevated (149&#160;&#177;&#160;10.62%, n&#160;=&#160;6 gels) c&#8208;Jun ubiquitination level in comparison to control neurons (NT). Values are presented as mean&#160;&#177;&#160;s.e.m. Statistical significance was determined by t&#8208;test. **P&#160;&lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>22497</offset>
      <text>Western blots showing knockdown (KD) or overexpression (OE) of PRR7 in primary hippocampal neurons do not alter levels of other FBW7 targets mTOR or Myc. Significance was determined using two&#8208;way ANOVA with Dunnett's post hoc test. Data are presented as mean&#160;&#177;&#160;s.e.m. All % values represent comparisons to control. **P&#160;&lt;&#160;0.01, ****P&#160;&lt;&#160;0.0001.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>22849</offset>
      <text>Source data are available online for this figure.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>22899</offset>
      <text>PRR7 forms a complex with c&#8208;Jun and FBW7</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>22942</offset>
      <text>To determine why PRR7 specifically inhibited c&#8208;Jun ubiquitination, we tested whether these proteins interact. We found that PRR7 co&#8208;immunoprecipitated with c&#8208;Jun when overexpressed in HEK293 cells (Fig&#160;5A). Pulldown experiments in&#160;vitro using purified proteins demonstrated that these proteins interact directly (Fig&#160;5B). The phosphodegron motif in PRR7 also suggested a direct interaction with FBW7. Indeed, PRR7 bound to FBW7 when overexpressed in HEK293 cells (Fig&#160;5C), in&#160;vitro using purified proteins (Fig&#160;5D), and also in rat brain lysates (Fig&#160;5E). To determine whether PRR7 blocked c&#8208;Jun ubiquitination by simple competition for FBW7 binding, we examined the interaction between PRR7, FBW7, and c&#8208;Jun in HEK293 cells. Surprisingly, PRR7 and FBW7 bound more strongly to c&#8208;Jun when both were cotransfected into heterologous cells (Fig&#160;5F), suggesting that a c&#8208;Jun/FBW7/PRR7 complex is stabilized in the presence of all components. This points to a more complex mechanism of inhibition rather than simple substrate sequestration.</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>23999</offset>
      <text>PRR7 interacts with c&#8208;Jun and the E3 ubiquitin ligase FBW7</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24060</offset>
      <text>Co&#8208;IPs of PRR7 with c&#8208;Jun from lysates of HEK293 cells overexpressing PRR7.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24140</offset>
      <text>Pulldown assays in&#160;vitro using purified proteins showed a direct interaction between PRR7 and c&#8208;Jun.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24244</offset>
      <text>Co&#8208;IPs of PRR7 with FBW7 from lysates of HEK293 cells overexpressing PRR7 and FBW7.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24330</offset>
      <text>Pulldown assays in&#160;vitro using purified PRR7 and FBW7.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24386</offset>
      <text>Co&#8208;IPs of endogenous PRR7 and FBW7 from lysates of rat brain.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24450</offset>
      <text>Co&#8208;IPs of PRR7 with c&#8208;Jun and FBW7 from lysates of HEK293 cells overexpressing PRR7 and FBW7. FBW7 expression increased the amount of c&#8208;Jun pulled down with PRR7 (n&#160;=&#160;4 gels for each panel, representative blots). (Lower bar graphs) Quantitation for Western blots show c&#8208;Jun/FBW7 binding is 41.4&#160;&#177;&#160;13.9% greater in the presence of PRR7 (normalized for FBW7 expression). Similarly, c&#8208;Jun/PRR7 binding is 97.4&#160;&#177;&#160;38.1% greater in the presence of FBW7 (normalized for PRR7 expression). Statistical significance was calculated using unpaired t&#8208;tests.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>25015</offset>
      <text>Source data are available online for this figure.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>25065</offset>
      <text>PRR7 regulates c&#8208;Jun&#8208;dependent transcription and NMDA&#8208;dependent excitotoxicity</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>25150</offset>
      <text>We hypothesized that regulating c&#8208;Jun ubiquitination would alter phosphorylated c&#8208;Jun levels (phospho&#8208;c&#8208;Jun) and thus c&#8208;Jun&#8208;dependent transcription, as phosphorylation of c&#8208;Jun enhances both its transcriptional activity and ubiquitination by FBW7 (Minden et&#160;al, 1995; Nateri et&#160;al, 2004). We found that PRR7 abundance was directly correlated with phospho&#8208;c&#8208;Jun (serine 63) levels in primary hippocampal neurons (Fig&#160;6A, black bars). As expected, PRR7 overexpression increased c&#8208;Jun transcriptional activity measured using an AP&#8208;1 reporter based luciferase assay in HEK293 cells (Fig&#160;6B). This increase in AP&#8208;1 transcriptional activity was likely mediated through changes in c&#8208;Jun alone, as c&#8208;Fos levels were not affected by PRR7 (Fig&#160;4A). To determine whether PRR7 regulated gene expression in neurons, we performed microarray experiments on neuronal cultures transduced with control (NT), PRR7 knockdown (KD), or PRR7 overexpression (OE) lentiviruses. We compared the KD/NT to OE/NT values to control for the effects of viral infection. Results analyzed using Ingenuity Pathway Analysis (IPA) software (Ingenuity systems) revealed significant reciprocal changes in survival and cellular death pathways in response to PRR7 knockdown or overexpression, respectively (Fig&#160;6C). The results also showed significant changes in c&#8208;Jun&#8208;specific target genes predicting decreased cell survival in neurons overexpressing PRR7 (Appendix&#160;Fig S5). Overall, manipulating PRR7 abundance significantly affected ~18% of RNAs analyzed (Tables EV1 and EV2) and the full microarray dataset was deposited at the NCBI database at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62686.</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>26857</offset>
      <text>PRR7 regulates c&#8208;Jun transcriptional activity and mediates NMDAR&#8208;dependent excitotoxicity</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>26951</offset>
      <text>Western blots of phospho&#8208;c&#8208;Jun in primary neuronal cultures. Quantification of phospho&#8208;c&#8208;Jun represents a ratio of phospho&#8208;c&#8208;Jun to total c&#8208;Jun, and all ratios were normalized to NT. PRR7 knockdown (KD) decreased, while PRR7 overexpression (OE) increased phospho&#8208;c&#8208;Jun levels (black bars). Glutamate stimulation (gray bars) increased phospho&#8208;c&#8208;Jun/c&#8208;Jun ratio in NT but not in KD or OE neurons (n&#160;=&#160;7 gels for all groups). Significance was determined using two&#8208;way ANOVA with Sidak's post hoc test.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>27478</offset>
      <text>AP&#8208;1&#8208;driven luciferase luminescence assays. PRR7 expression in HEK293 cells increased AP&#8208;1 activity (190.6&#160;&#177;&#160;13.9%, n&#160;=&#160;12; RLU&#160;=&#160;relative light units). Statistical significance was determined using t&#8208;tests.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>27701</offset>
      <text>Ingenuity Pathway Analysis (IPA)&#8208;predicted cellular functions based on microarray analysis. Functions are sorted by P&#8208;value (highest top).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>27844</offset>
      <text>Quantitation of cell death using 30&#160;min of PI in&#160;situ staining following 48&#160;h of WT&#8208;PRR7&#8208;GFP or mNLS&#8208;PRR7&#8208;GFP overexpression in primary hippocampal neuronal cultures (n&#160;=&#160;24 cells per group). Images represent a max projection of five z&#8208;stack sections across the cell body.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>28132</offset>
      <text>NMDA treatment (25&#160;min, 100&#160;&#956;M followed by 14&#160;h chase) caused 83.6&#160;&#177;&#160;3.5% cell death in control neurons compared to 60.3&#160;&#177;&#160;4.6% cell death in neurons with PRR7 expression knocked down. A c&#8208;Jun inhibitory peptide reduced NMDA&#8208;mediated cell death to 66.2&#160;&#177;&#160;6.0% in control neurons and to 55.6&#160;&#177;&#160;5.3% in neurons knocked down for PRR7, but this difference was not statistically significant (n&#160;=&#160;5 independent experiments). Two&#8208;way ANOVA was used in conjugation with Tukey's post hoc test. (Left) Representative images showing transduced neurons (green, GFP) and PI staining (red).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>28733</offset>
      <text>Quantification of cell death in response to NMDA stimulation in the presence or absence of PRR7 and either WT c&#8208;Jun or a dominant negative c&#8208;Jun4A (4A). Overexpression of WT c&#8208;Jun caused extensive neuronal cell death (84.8&#160;&#177;&#160;2.4%) that was reduced in neurons knocked down for PRR7 (43.8&#160;&#177;&#160;9.2). Overexpressing 4A conferred neuroprotection to NMDA excitotoxicity (50.8&#160;&#177;&#160;7.9%) but was not additive with PRR7 knockdown (42.3&#160;&#177;&#160;8.1%) (n&#160;=&#160;3 independent experiments). Significance was determined using two&#8208;way ANOVA in conjugation with Tukey's post hoc test. Images are representative 10X widefield micrographs showing transduced neurons (green, GFP) and PI staining (red). Data are presented as mean&#160;&#177;&#160;s.e.m. All % values represent comparisons to control. *P&#160;&lt;&#160;0.05.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>29524</offset>
      <text>Source data are available online for this figure.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>29574</offset>
      <text>Given the microarray results, we next tested the effects of PRR7 on neuronal viability by overexpressing PRR7 in neuronal cultures and using propidium iodide staining (PI) in&#160;situ to identify dead cells. Expression of full&#8208;length PRR7 (WT&#8208;PRR7&#8208;GFP) for 48&#160;h caused substantial cell death compared to the expression of GFP alone (Fig&#160;6D). We compared WT&#8208;PRR7&#8208;GFP to mNLS&#8208;PRR7&#8208;GFP (mutant nuclear localization sequence), which is a full&#8208;length PRR7 protein mutated to contain five point substitutions within the NLS that substitutes lysine/arginine residues with alanine (K39A&#8208;R40A&#8208;R41A&#8208;R45A&#8208;R47A). mNLS&#8208;PRR7&#8208;GFP was not present in the nucleus following heterologous expression and did not cause cell death, suggesting that nuclear PRR7 was responsible for this effect (Fig&#160;6D).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>30383</offset>
      <text>As PRR7 accumulates in the nucleus following NMDAR stimulation (Fig&#160;2), we hypothesized that it may play a role in NMDAR&#8208;dependent excitotoxicity. To test this prediction, we first confirmed that glutamate stimulation increased c&#8208;Jun phosphorylation (Pozniak et&#160;al, 2013) in primary hippocampal cultures (Fig&#160;6A, gray bars) and found that this was blocked following PRR7 knockdown (Fig&#160;6A). On the other hand, overexpression of PRR7&#8208;elevated phospho&#8208;c&#8208;Jun levels, but similar to PRR7 knockdown, abolished its regulation by glutamate stimulation. These results suggested that PRR7 inhibited the ubiquitination of phospho&#8208;c&#8208;Jun by FBW7. To explore the functional implications of this regulation, we examined the effects of PRR7 knockdown on NMDAR&#8208;mediated excitotoxicity. We treated neuronal cultures with NMDA (100&#160;&#956;M, 25&#160;min) and examined cell death using PI 14&#160;h later. Loss of PRR7 had no significant effect on cell survival in untreated neurons. However, PRR7 knockdown significantly reduced NMDA&#8208;triggered excitotoxicity compared to control neurons (Fig&#160;6E). These effects were not due to changes in NMDA or synaptic function as manipulating PRR7 abundance had no effect on NMDA or miniature AMPA&#8208;mediated currents in primary neuronal cultures (Appendix&#160;Fig S3).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>31680</offset>
      <text>To determine whether the neuroprotective effects of PRR7 knockdown required c&#8208;Jun, we used a cell permeable c&#8208;Jun inhibitor peptide that blocks c&#8208;Jun/JNK complex formation (Holzberg et&#160;al, 2003). We found that c&#8208;Jun inhibition partially rescued neurons from NMDAR&#8208;mediated excitotoxicity and that the extent of protection was similar to that obtained by PRR7 knockdown (Fig&#160;6E). However, a combination of c&#8208;Jun inhibition and PRR7 knockdown did not have any additive effects (Fig&#160;6E), suggesting that both c&#8208;Jun and PRR7 act through a similar signaling pathway. To further test this notion, we used a dominant negative c&#8208;Jun construct (c&#8208;Jun4A) that cannot be phosphorylated (Nateri et&#160;al, 2004) or activated (Pulverer et&#160;al, 1991; Smeal et&#160;al, 1991). As previously described (Estus et&#160;al, 1994; Ham et&#160;al, 1995), overexpression of WT c&#8208;Jun led to high rates of neuronal cell death even in the absence of NMDA&#8208;dependent stimulation (Fig&#160;6F, black bars). Importantly, PRR7 knockdown partially rescued this effect, suggesting that PRR7 plays a role in c&#8208;Jun&#8208;mediated neuronal death. While overexpression of c&#8208;Jun4A did not cause neuronal death under control conditions (Fig&#160;6F, gray bars), c&#8208;Jun4A could partially rescue neurons from NMDAR&#8208;mediated excitotoxicity as expected from previous work (Behrens et&#160;al, 1999) (Fig&#160;6F, gray bars, NMDA). However, this rescue was not additive with the effects of PRR7 knockdown (Fig&#160;6F). Taken together, these results show that PRR7 mediates NMDAR&#8208;dependent excitotoxicity through the regulation of c&#8208;Jun function and that PRR7 knockdown has neuroprotective effects.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>33333</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>33344</offset>
      <text>Here, we show that PRR7 is a novel regulator of c&#8208;Jun ubiquitination and function in hippocampal neurons. Our data suggest that PRR7 is a synapse&#8208;to&#8208;nucleus messenger that links NMDAR activity to c&#8208;Jun&#8208;dependent transcription by inhibiting its FBW7&#8208;mediated ubiquitination. This activity&#8208;dependent ubiquitination of a transcription factor represents an additional mechanism through which synaptic activity can regulate gene expression in neurons. Overall, this work provides new insights into NMDAR&#8208;mediated neuronal excitotoxicity, which is associated with changes in total and phosphorylated c&#8208;Jun levels (Dragunow et&#160;al, 1993; Munemasa et&#160;al, 2006).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>34017</offset>
      <text>Our data demonstrate an increase in nuclear PRR7 levels following glutamate stimulation that is not affected by inhibitors of proteasomal degradation or protein synthesis, thus implicating a transport process. Synapse&#8208;to&#8208;nucleus transport is supported by experiments using the monomeric photoswitchable fluorescent protein mEos (Wiedenmann et&#160;al, 2004; Zhang et&#160;al, 2012b), which show that photoconverted PRR7 at distal dendrites shuttles to the nucleus following stimulation with NMDA, and by FRAP experiments, which show that PRR7&#8208;GFP accumulates in the nucleus following activation of NMDAR. However, we did not detect a &#8220;ring&#8221;&#8208;like pattern around the nucleus expected given the predicted transmembrane domain on PRR7 and given that membrane bound proteins enter the nucleus via lateral diffusion (King et&#160;al, 2006). Instead, PRR7 exhibits a diffuse and often punctate nuclear distribution. This suggests that either PRR7 is not membrane associated as predicted, or is released via limited proteolysis, which is a common mechanism in the transport of C&#8208;terminal fragments of transmembrane proteins including APP, N&#8208;cadherin, or protocadherins (Jordan &amp; Kreutz, 2009). Alternatively, PRR7 may be associated with intranuclear lipid microdomains that bind DNA and protein complexes (Irvine, 2003). An understanding of the mechanisms underlying the nuclear accumulation of PRR7 will require additional experiments.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>35450</offset>
      <text>The present work suggests that NMDAR activity leads to increased c&#8208;Jun phosphorylation because a rise in nuclear PRR7 inhibits the ubiquitination of phospho&#8208;c&#8208;Jun by FBW7. Therefore, we describe here an activity&#8208;dependent mechanism to regulate gene expression by inhibition of ubiquitination. This mechanism is different from others involved in activity&#8208;dependent changes in gene expression, which can rely on phosphorylation (CREB), nuclear translocation (NF&#8208;&#954;B, NFATc4) or upregulation (c&#8208;Fos) of transcription factors (West &amp; Greenberg, 2011). Such a mechanism might keep phosphorylated c&#8208;Jun levels high for a short time window without requiring new transcription.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>36136</offset>
      <text>As an inhibitor of c&#8208;Jun ubiquitination, it was surprising that PRR7 forms a high&#8208;affinity complex with FBW7 and c&#8208;Jun (Fig&#160;5F). However, other inhibitors of FBW7 such as NEMO and Rack1 function in a similar way (Kim et&#160;al, 2010; Zhang et&#160;al, 2012a). Rack1 blocks phospho&#8208;c&#8208;Jun ubiquitination by forming a high&#8208;affinity ternary complex with FBW7 and non&#8208;phosphorylated c&#8208;Jun (Zhang et&#160;al, 2012a), which allows transcriptionally active phospho&#8208;c&#8208;Jun to escape degradation. This mechanism may provide specificity and thus spare alternative FBW7 substrates. Indeed, we have shown that PRR7 expression does not affect protein levels of the FBW7 substrates Myc and mTOR (Fig&#160;4 and Appendix&#160;Fig S4). However, whether PRR7 can recruit phosphorylated or non&#8208;phosphorylated c&#8208;Jun into a complex with FBW7 is unclear at present.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>36985</offset>
      <text>While the present study implicates PRR7 in excitotoxicity, its neuronal function may be context dependent as diverse synaptic stimuli differentially regulate neuronal processes (Hardingham et&#160;al, 2002; Dieterich et&#160;al, 2008). For example, synaptic or extrasynaptic NMDAR activation results in the synapse&#8208;to&#8208;nucleus translocation of the CREB regulator Jacob (Dieterich et&#160;al, 2008; Karpova et&#160;al, 2013). However, synaptic activity leads to CREB phosphorylation and activation, while extrasynaptic activation of NMDARs triggers the CREB shutoff pathway and neuronal degeneration (Hardingham et&#160;al, 2002; Karpova et&#160;al, 2013). Cellular stress activates the AP&#8208;1 complex (Coffey, 2014) to promote either cell survival or apoptosis (Herdegen et&#160;al, 1997). As c&#8208;Jun has been implicated in synaptic plasticity and axon regeneration (Alberini, 2009), other stimuli that regulate AP&#8208;1 transcription such as BDNF&#8208; or plasticity&#8208;inducing protocols (Gaiddon et&#160;al, 1996; Herdegen &amp; Waetzig, 2001) may regulate PRR7 nuclear abundance.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>38030</offset>
      <text>Our microarray results predict a decrease in cell survival/viability in neurons overexpressing PRR7 (Fig&#160;6C) that is strongly associated with changes in c&#8208;Jun&#8208;specific target genes (Appendix&#160;Fig S5) including Fos, Csf1r, and Cdkn1b. However, we also find changes in Bdnf as well as other transcripts controlled by CREB activity (Tao et&#160;al, 1998), which is not surprising given that CREB expression lies downstream of AP&#8208;1 transcriptional activity (Sanyal et&#160;al, 2002). Indeed, we find that the manipulation of PRR7 abundance results in extensive changes in the cellular transcriptome (Tables EV1 and EV2), which illustrates how difficult it is to disentangle causality in transcriptional programs and microarray assays.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>38760</offset>
      <text>To conclude, our study shows that PRR7 is an NMDAR&#8208;dependent nuclear messenger that regulates gene expression via inhibition of c&#8208;Jun ubiquitination. We demonstrate that the nuclear accumulation of PRR7 is necessary for its effects on cellular viability, suggesting that its effects on excitotoxicity involve the regulation of gene expression. To our knowledge, this is the first evidence linking NMDAR activity to transcriptional control via regulation of ubiquitination. Moreover, the novel role for PRR7 as a messenger between pathological activation of NMDAR, increased c&#8208;Jun function, and cell death provides insights into the molecular processes that underlie NMDAR&#8208;dependent excitotoxicity.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>39466</offset>
      <text>Materials and Methods</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>39488</offset>
      <text>Patch&#8208;clamp recordings in HEK293T cells and primary neurons</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>39550</offset>
      <text>Cells were patched in the whole&#8208;cell mode as described previously (Karpova et&#160;al, 2013). The extracellular medium contained 145&#160;mM NaCl, 2.5&#160;mM KCl, 2&#160;mM CaCl2, 10&#160;mM HEPES, 10&#160;mM d&#8208;glucose, 1&#160;&#956;M TTX, 10&#160;&#956;M bicuculline, and 10&#160;&#956;M CNQX in the experiments recording NMDA currents. In these experiments, NMDA 100&#160;&#956;M and glycine 10&#160;&#956;M, dissolved in extracellular solution, were puffed onto the soma. For experiments where AMPA&#8208;mediated mEPSCs were recorded, the extracellular solution contained 145&#160;mM NaCl, 2.5&#160;mM KCl, 2&#160;mM MgCl2, 2&#160;mM CaCl2, 10&#160;mM HEPES, 10&#160;mM d&#8208;glucose, 1&#160;&#956;M TTX, 10&#160;&#956;M bicuculline, and 10&#160;&#956;M APV. The intracellular solution contained in all cases 140&#160;mM potassium gluconate, 10&#160;mM EGTA, 10&#160;mM HEPES, 2&#160;mM MgCl2, 1&#160;mM CaCl2, 4&#160;mM NaATP, and 0.4&#160;mM GTP. Patch pipettes (3&#8211;5&#160;M&#937;) were pulled from thick&#8208;walled borosilicate glass tubing. Recordings were performed with an EPC9 patch&#8208;clamp amplifier. Data were acquired and stored using Patchmaster and analyzed with Fitmaster and GraphPad Prism. Patch&#8208;clamp recordings of primary neurons in the presence of NMDA were done at DIV21 while neurons were infected at DIV14. mEPSC amplitude and frequency were measured at DIV16 while neurons were infected at DIV11. HEK cells were transfected 2&#160;days before recording.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>40878</offset>
      <text>Fluorescence recovery after photobleaching and photoconversion assay</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>40947</offset>
      <text>All time&#8208;lapse experiments were performed on the upright SP5 CLSM system (Leica Microsystems, Mannheim, Germany) equipped with diode (405&#160;nm), argon (488&#160;nm), and diode&#8208;pumped solid&#8208;state (561&#160;nm) lasers, and images were taken with HCX APO L20&#215;/1.00W objective (Leica, Germany). Quick change 18&#160;mm chamber (RC&#8208;41LP, Warner Instruments) was used for mounting coverslips with neurons expressing PRR7&#8208;mEos on the microscope stage. We bleached GFP fluorescence in the nucleus by high argon laser (488&#160;nm) power and used a hybrid detector (HyD) from Leica Microsystems (Wetzlar) to detect low expression levels of PRR7&#8208;GFP under low&#8208;light excitation to prevent overexpression and phototoxicity artefacts. NMDA (50&#160;&#956;M) was added directly to neurobasal medium immediately after acquisition of the frame t0. MK801 (10&#160;&#956;M) and TTX (1&#160;&#956;M) were kept in the medium overnight prior to and during data acquisition. Photoconversion experiments were performed as described previously (Dinamarca et&#160;al, 2016). Distal dendrites, indicated as ROIs in 17&#8211;19 DIV primary hippocampal neurons expressing PRR7&#8208;mEos, were selected for photoconversion and illuminated with UV laser (405&#160;nm) along the z&#8208;axis with a focal depth of 300&#8211;400&#160;nm. After photoconversion, NMDA was added directly to the neurobasal culture media. For detection of photoconverted mEos, we used the hybrid detector (HyD) from Leica Microsystems (Wetzlar).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>42387</offset>
      <text>Neuronal imaging and propidium iodide uptake cell death assay</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>42449</offset>
      <text>Double colocalization analyses (JaCoP) and triple colocalization analyses (BlobProb) were performed using the respective add&#8208;ins in&#160;ImageJ (NIH) and as described previously (Klein et&#160;al, 2013). Quantitative analysis of immunocytochemistry experiments was performed blind to the stimulation used or identity of viruses used for infection. Dead cells in neuronal cultures co&#8208;expressing GFP, WT&#8208;PRR7&#8208;GFP, or mNLS&#8208;PRR7&#8208;GFP were stained with propidium iodide (1&#8211;2&#160;mg/ml) added to culture medium 48&#160;h after transfection. All GFP&#8208;positive neurons were counted in each condition and either classified as dead (propidium iodide positive) or alive (propidium iodide negative). For excitotoxicity experiments, hippocampal cells were transduced with a control non&#8208;targeting shRNA (NT)&#8208; or PRR7 shRNA&#8208;expressing viruses at DIV13 and were treated with 100&#160;&#956;M NMDA at DIV21, chased for 14&#160;h, and then imaged using propidium iodide. To inhibit c&#8208;Jun activity, we used a cell permeable c&#8208;Jun peptide inhibitor (Tocris) that blocks JNK/c&#8208;Jun interactions (Holzberg et&#160;al, 2003). We added 100&#160;&#956;M peptide 1&#160;h prior to NMDA stimulation as above. WT or 4A&#8208;cJun was transfected into neurons 12&#160;h prior to NMDA stimulation. Imaging of neurons and further analysis of cell death were carried out blind to the viral transduction and condition of treatment.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>43822</offset>
      <text>Cell cultures</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>43836</offset>
      <text>Sprague&#8208;Dawley rats were killed using CO2&#160;according to the guidelines of the Albert Einstein College of Medicine Institutional Animal Care and Use Committee. Primary hippocampal neuronal cultures from embryonic day (18&#8211;19) embryos of either sex were prepared as described (Osten et&#160;al, 2000). HEK293 cells were cultured in&#160;Dulbecco's modified Eagle's medium (DMEM, Gibco) supplemented&#160;with 10% v/v fetal bovine serum and antibiotics penicillin (100&#160;U/ml) and streptomycin (100&#160;&#956;g/ml). HEK293 cells were transfected using a standard calcium phosphate method. When overexpressing NMDAR subunits in HEK293 cells, the medium was supplemented with 500&#160;&#956;M ketamine and 20&#160;mM MgCl2 after transfection to prevent NMDAR&#8208;induced cell death. High&#8208;density cortical cultures were prepared from rat embryos (day 18&#8211;19) and as described in Osten et&#160;al (2000) with the modification of plating cells at a density of 50,000 per cm2.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>44772</offset>
      <text>Plasmids, antibodies, and lentiviral vectors</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>44817</offset>
      <text>We used pTRIP vectors to generate lentiviral shRNA vectors for knockdown following the methods previously described (Janas et&#160;al, 2006). The sequence used to knockdown PRR7 targeted the coding region of PRR7: 413&#160;bp [5&#8242;&#8208; CGGAATCGGACATGTCTAA 3&#8242;]. To overexpress PRR7, we subcloned full&#8208;length PRR7 into FUGW vector (Dittgen et&#160;al, 2004). Viral particles were produced as described previously (Klein et&#160;al, 2013). Plasmids encoding human PRR7, PRR7&#8208;GFP, and PRR7(1&#8208;44)&#8208;GFP were generated previously (Hrdinka et&#160;al, 2011). Fl&#8208;mNLS&#8208;PRR7&#8208;GFP (K39A&#8208;R40A&#8208;R41A&#8208;R45A&#8208;R47A) was generated employing PCR fast cloning followed by homologous recombination approach with the following primers: rev&#8212;5&#8242;GCCTCCTCCTGGGCCGCTGCGAGGCGGCGGCGCAGG&#8208;3&#8242; and fw&#8212;5&#8242;&#8208;GGCCCAGGAGGAGGCACTGGCCGAGCAGAACCTGCGC&#8208;3&#8242;. PRR7&#8208;mEos was generated by cloning full&#8208;length PRR7 into the N&#8208;terminus of the monomeric EosFP protein mEos3.2 variant (Zhang et&#160;al, 2012b), which was a gift from Michael Davidson (Addgene plasmid # 54550). C&#8208;terminally tagged PRR7&#8208;Myc and PRR7&#8208;Flag constructs were created by subcloning PRR7 into pRK&#8208;Myc and pFLAG&#8208;CMV vectors, respectively. The N&#8208;terminal deletion mutant PRR7 (34&#8211;269)&#8208;GFP was generated by PCR and inserted into pEGFP&#8208;C2 vector (Clontech). The rat GluN1 and GluN2B&#8208;Myc constructs were kindly provided by M. Horak (Prague). The rat GluA1 and GluA2&#8208;Myc constructs were obtained from M. Heine (Magdeburg). We generated PRR7&#8208;myc&#8208;His plasmid by cloning full&#8208;length PRR7 into pCDNA3.1 vector (Invitrogen). WT&#8208;cJun and 4A&#8208;cJun plasmids were a gift from Axel Behrens (Addgene plasmids #47443 and #47444). HA&#8208;tagged ubiquitin was a gift from Paul Lombroso (Yale University). pFlag&#8208;FBW7beta was a gift from Bruce Clurman (University of Washington). AP1(5x) Luc vector was a gift from George Wilding (University of Wisconsin). Antibodies used were as follows: PRR7 (1:2,000, Rb polyclonal; for imaging) a gift from Yoshinori Fujiyoshi (Nagoya University) and PRR7 (1:1,000, mouse monoclonal; Thermo Scientific) both were previously described (Murata et&#160;al, 2005; Hrdinka et&#160;al, 2011). Additional antibodies used were as follows: GluN1 (1:1,000, Chemicon); Shank (1:1,000; UC Davis/NIH NeuroMab Facility); GAPDH (1:5,000; GeneTex); SNAP25 (1:1,000, abcam); fibrillarin (1:500; Developmental Studies Hybridoma Bank, University of Iowa); c&#8208;Myc (sc&#8208;40; 1:2,000; Santa Cruz); c&#8208;Jun (1:1,000; Cell Signaling Technology); phospho&#8208;c&#8208;Jun (60A8 targeting serine 63; 1:1,000; Cell Signaling Technology); HA (1:2,000; Thermo Scientific); Flag (M2; 1:5,000; Sigma&#8208;Aldrich); polyubiquitin K&#8208;GG (GX41; 1:1,000; Lucerna); GFP (B34; 1:2,000; Covance); PSD95 (K28/43; 1:1,000, UC Davis/NIH NeuroMab Facility); synaptic vesicle 2 (SV2; 1:150 Developmental Studies Hybridoma Bank, University of Iowa), MAP2 (1:1,000; EncoreBio); and Bassoon (1:1,000; Synaptic Systems).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>47762</offset>
      <text>Subcellular fractionation</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47788</offset>
      <text>Fractionation of synaptic and nuclear as well as other cellular compartments was carried out as previously described (Klein et&#160;al, 2013).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>47927</offset>
      <text>Ubiquitination assay</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47948</offset>
      <text>HEK293 cells were transfected with HA&#8208;ubiquitin and Flag&#8208;FBW7 with or without PRR7 or PSD95 as a control. In neuronal cultures, we knocked down PRR7 in primary hippocampal cultures from DIV10&#8211;17. Twenty&#8208;four hours after transfection in HEK293 cells or 7&#160;days following viral transduction in neurons, cells were treated with MG132 for 4&#160;h and lysed with 2% SDS, 50&#160;mM Tris pH 8.0, boiled for 5&#160;min and sonicated. Lysates were then diluted 10&#8208;fold with 1% Triton X&#8208;100, 75&#160;mM NaCl, 10% glycerol, 2&#160;mM EDTA, 50&#160;mM Tris pH 8.0 and rocked at 4&#176;C for 1&#160;h. One microgram of c&#8208;Jun antibody was then added overnight at 4&#176;C, and immunoprecipitation (IP) was carried out according to standard procedures. Following the IP, eluates were subjected to SDS&#8211;PAGE and Western blots carried out using anti&#8208;HA antibodies (in cells) or poly&#8208;Ub antibody (in neurons). Western blot quantifications were done by densitometry using ImageJ.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>48894</offset>
      <text>Microarray</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>48905</offset>
      <text>We used our optimized protocol (Iacobas et&#160;al, 2013) to cohybridize differently labeled biological replicas with each array [&#8220;multiple yellow&#8221; strategy (Soares et&#160;al, 2010)] of Agilent rat two&#8208;color gene expression 4&#160;&#215;&#160;44&#160;k arrays. Total RNA was extracted with Qiagen RNeasy mini&#8208;kit, concentration determined with a NanoDrop ND&#8208;2000 Spectrophotometer and purity with Agilent RNA 6000 Nano kit in an Agilent 2100 Bioanalyzer. Total RNA was reverse transcribed in the presence of Cy3/Cy5 dUTP, and the incorporation of the fluorescent tags was determined with the NanoDrop. The arrays were scanned with an Agilent G2539A dual laser scanner and primary analysis performed with (Agilent) Feature Extraction 11.1 software. All spots affected by local corruption or with foreground fluorescence less than twice the background were disregarded and data normalized and analyzed following our standard procedure (Iacobas et&#160;al, 2013). The gene expression data complying with the &#8220;Minimum Information about Microarray Experiments&#8221; (MIAME) were deposited at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62686</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>50033</offset>
      <text>IPA analysis</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>50046</offset>
      <text>Microarray results considered as significantly changed between NT and KD or OE conditions were such that showed a 1.5&#8208;fold difference between the samples and exhibited a P&#8208;value&#160;&lt;&#160;0.05. Activation Z&#8208;score was calculated by IPA software and represents a significance measure that predicts the activation states of transcriptional regulators or the trend of a biological process. Functional analyses of KD and OE (Fig&#160;6C) were organized by ascending Z&#8208;score values and opposing trend of the KD analysis. All the functional analyses and upstream activation networks were generated through the use of QIAGEN's Ingenuity Pathway Analysis (IPA&#174;QIAGEN Redwood City, www.qiagen.com/ingenuity).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>50744</offset>
      <text>Luciferase assay</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>50761</offset>
      <text>Approximately 70,000 HEK293 cells were transfected with 50&#160;ng of AP1(5x)Luc, pEGFP, and PRR7mycHis or PSD95mycHis (as control). Luciferase luminescence was measured 24&#160;h following transfection using a Beckman DTX800 Microplate reader and normalized to GFP fluorescence to account for variability in transfection efficiency.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>51087</offset>
      <text>Statistical analysis</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>51108</offset>
      <text>Student's t&#8208;test was carried out for comparison of two groups. Comparison of more than two groups was carried out using one&#8208;way ANOVA using multiple comparisons where appropriate. Post hoc testing of ANOVA was selected based on conditions and indicated in the figure legends. Two&#8208;way ANOVA was used in cases where two variables were introduced (e.g. treatment and infection). For all figures, P&#8208;values of comparison between experimental results are depicted as&#160;follows: *P&#160;&lt;&#160;0.05, **P&#160;&lt;&#160;0.01, ***P&#160;&lt;&#160;0.001, ****P&#160;&lt;&#160;0.0001. &#8220;n.s.&#8221; indicates a P&#8208;value&#160;&gt;&#160;0.05. All values are presented as mean&#160;&#177;&#160;s.e.m. and all reported % values are compared to controls.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>51788</offset>
      <text>Author contributions</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>51809</offset>
      <text>DOK, AK, MH, JLR, AUC, MRK, and BAJ designed and performed all the biochemical and imaging experiments and analyzed the data; SI, DAI, and DOK performed and analyzed the microarray assays. DOK, MRK, and BAJ wrote the manuscript.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>52038</offset>
      <text>Conflict of interest</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>52059</offset>
      <text>The authors declare that they have no conflict of interest.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>52119</offset>
      <text>Supporting information</text>
    </passage>
    <passage>
      <infon key="type">title</infon>
      <offset>52142</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="volume">89</infon>
      <infon key="source">Physiol Rev</infon>
      <infon key="lpage">145</infon>
      <infon key="pub-id_pmid">19126756</infon>
      <infon key="fpage">121</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>52153</offset>
      <text>Transcription factors in long&#8208;term memory and synaptic plasticity</text>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="lpage">329</infon>
      <infon key="pub-id_pmid">10080190</infon>
      <infon key="fpage">326</infon>
      <infon key="year">1999</infon>
      <infon key="type">ref</infon>
      <offset>52221</offset>
      <text>Amino&#8208;terminal phosphorylation of c&#8208;Jun regulates stress&#8208;induced apoptosis and cellular proliferation</text>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="source">Nat Rev Neurosci</infon>
      <infon key="lpage">299</infon>
      <infon key="pub-id_pmid">24739785</infon>
      <infon key="fpage">285</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>52329</offset>
      <text>Nuclear and cytosolic JNK signalling in neurons</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="source">EMBO J</infon>
      <infon key="lpage">1344</infon>
      <infon key="pub-id_pmid">10064599</infon>
      <infon key="fpage">1335</infon>
      <infon key="year">1999</infon>
      <infon key="type">ref</infon>
      <offset>52377</offset>
      <text>c&#8208;Jun functions as a calcium&#8208;regulated transcriptional activator in the absence of JNK/SAPK1 activation</text>
    </passage>
    <passage>
      <infon key="volume">26</infon>
      <infon key="source">Cancer Cell</infon>
      <infon key="lpage">464</infon>
      <infon key="pub-id_pmid">25314076</infon>
      <infon key="fpage">455</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>52485</offset>
      <text>Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities</text>
    </passage>
    <passage>
      <infon key="source">PLoS Biol</infon>
      <infon key="volume">6</infon>
      <infon key="pub-id_pmid">18303947</infon>
      <infon key="fpage">e34</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>52562</offset>
      <text>Caldendrin&#8208;Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus</text>
    </passage>
    <passage>
      <infon key="source">Elife</infon>
      <infon key="volume">5</infon>
      <infon key="pub-id_pmid">26977767</infon>
      <infon key="fpage">e12430</infon>
      <infon key="year">2016</infon>
      <infon key="type">ref</infon>
      <offset>52653</offset>
      <text>Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus</text>
    </passage>
    <passage>
      <infon key="volume">101</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">18211</infon>
      <infon key="pub-id_pmid">15608064</infon>
      <infon key="fpage">18206</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>52765</offset>
      <text>Lentivirus&#8208;based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in&#160;vivo</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="source">Brain Res Mol Brain Res</infon>
      <infon key="lpage">352</infon>
      <infon key="pub-id_pmid">8326831</infon>
      <infon key="fpage">347</infon>
      <infon key="year">1993</infon>
      <infon key="type">ref</infon>
      <offset>52889</offset>
      <text>Is c&#8208;Jun involved in nerve cell death following status epilepticus and hypoxic&#8208;ischaemic brain injury?</text>
    </passage>
    <passage>
      <infon key="volume">127</infon>
      <infon key="source">J Cell Biol</infon>
      <infon key="lpage">1727</infon>
      <infon key="pub-id_pmid">7798322</infon>
      <infon key="fpage">1717</infon>
      <infon key="year">1994</infon>
      <infon key="type">ref</infon>
      <offset>52996</offset>
      <text>Altered gene expression in neurons during programmed cell death: identification of c&#8208;jun as necessary for neuronal apoptosis</text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="source">Nat Immunol</infon>
      <infon key="lpage">287</infon>
      <infon key="pub-id_pmid">11828324</infon>
      <infon key="fpage">281</infon>
      <infon key="year">2002</infon>
      <infon key="type">ref</infon>
      <offset>53123</offset>
      <text>Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation</text>
    </passage>
    <passage>
      <infon key="volume">66</infon>
      <infon key="source">J Neurochem</infon>
      <infon key="lpage">2286</infon>
      <infon key="pub-id_pmid">8632149</infon>
      <infon key="fpage">2279</infon>
      <infon key="year">1996</infon>
      <infon key="type">ref</infon>
      <offset>53216</offset>
      <text>Brain&#8208;derived neurotrophic factor stimulates AP&#8208;1 and cyclic AMP&#8208;responsive element dependent transcriptional activity in central nervous system neurons</text>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="source">Neuron</infon>
      <infon key="lpage">939</infon>
      <infon key="pub-id_pmid">7748560</infon>
      <infon key="fpage">927</infon>
      <infon key="year">1995</infon>
      <infon key="type">ref</infon>
      <offset>53375</offset>
      <text>A c&#8208;Jun dominant negative mutant protects sympathetic neurons against programmed cell death</text>
    </passage>
    <passage>
      <infon key="volume">5</infon>
      <infon key="source">Nat Neurosci</infon>
      <infon key="lpage">414</infon>
      <infon key="pub-id_pmid">11953750</infon>
      <infon key="fpage">405</infon>
      <infon key="year">2002</infon>
      <infon key="type">ref</infon>
      <offset>53469</offset>
      <text>Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut&#8208;off and cell death pathways</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Trends Neurosci</infon>
      <infon key="lpage">231</infon>
      <infon key="pub-id_pmid">9141200</infon>
      <infon key="fpage">227</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>53567</offset>
      <text>The c&#8208;Jun transcription factor&#8211;bipotential mediator of neuronal death, survival and regeneration</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Oncogene</infon>
      <infon key="lpage">2437</infon>
      <infon key="pub-id_pmid">11402338</infon>
      <infon key="fpage">2424</infon>
      <infon key="year">2001</infon>
      <infon key="type">ref</infon>
      <offset>53668</offset>
      <text>AP&#8208;1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration</text>
    </passage>
    <passage>
      <infon key="volume">278</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">40223</infon>
      <infon key="pub-id_pmid">12832416</infon>
      <infon key="fpage">40213</infon>
      <infon key="year">2003</infon>
      <infon key="type">ref</infon>
      <offset>53779</offset>
      <text>Disruption of the c&#8208;JUN&#8208;JNK complex by a cell&#8208;permeable peptide containing the c&#8208;JUN delta domain induces apoptosis and affects a distinct set of interleukin&#8208;1&#8208;induced inflammatory genes</text>
    </passage>
    <passage>
      <infon key="volume">286</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">19629</infon>
      <infon key="pub-id_pmid">21460222</infon>
      <infon key="fpage">19617</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>53978</offset>
      <text>PRR7 is a transmembrane adaptor protein expressed in activated T cells involved in regulation of T cell receptor signaling and apoptosis</text>
    </passage>
    <passage>
      <infon key="volume">35</infon>
      <infon key="source">J Neurosci</infon>
      <infon key="lpage">395</infon>
      <infon key="pub-id_pmid">25568130</infon>
      <infon key="fpage">386</infon>
      <infon key="year">2015</infon>
      <infon key="type">ref</infon>
      <offset>54115</offset>
      <text>cJun and CREB2 in the postsynaptic neuron contribute to persistent long&#8208;term facilitation at a behaviorally relevant synapse</text>
    </passage>
    <passage>
      <infon key="volume">25</infon>
      <infon key="source">J Neuroendocrinol</infon>
      <infon key="lpage">979</infon>
      <infon key="pub-id_pmid">23763471</infon>
      <infon key="fpage">964</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>54242</offset>
      <text>Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="source">Nat Rev Mol Cell Biol</infon>
      <infon key="lpage">360</infon>
      <infon key="pub-id_pmid">12728269</infon>
      <infon key="fpage">349</infon>
      <infon key="year">2003</infon>
      <infon key="type">ref</infon>
      <offset>54381</offset>
      <text>Nuclear lipid signalling</text>
    </passage>
    <passage>
      <infon key="volume">406</infon>
      <infon key="source">Methods Enzymol</infon>
      <infon key="lpage">605</infon>
      <infon key="pub-id_pmid">16472690</infon>
      <infon key="fpage">593</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>54406</offset>
      <text>Lentiviral delivery of RNAi in hippocampal neurons</text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="source">Mol Cell Proteomics</infon>
      <infon key="lpage">871</infon>
      <infon key="pub-id_pmid">15169875</infon>
      <infon key="fpage">857</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>54457</offset>
      <text>Identification and verification of novel rodent postsynaptic density proteins</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="source">Trends Neurosci</infon>
      <infon key="lpage">401</infon>
      <infon key="pub-id_pmid">19524307</infon>
      <infon key="fpage">392</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>54535</offset>
      <text>Nucleocytoplasmic protein shuttling: the direct route in synapse&#8208;to&#8208;nucleus signaling</text>
    </passage>
    <passage>
      <infon key="volume">152</infon>
      <infon key="source">Cell</infon>
      <infon key="lpage">1133</infon>
      <infon key="pub-id_pmid">23452857</infon>
      <infon key="fpage">1119</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>54625</offset>
      <text>Encoding and transducing the synaptic or extrasynaptic origin of NMDA receptor signals to the nucleus</text>
    </passage>
    <passage>
      <infon key="volume">584</infon>
      <infon key="source">FEBS Lett</infon>
      <infon key="lpage">4530</infon>
      <infon key="pub-id_pmid">20970423</infon>
      <infon key="fpage">4524</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>54727</offset>
      <text>NEMO stabilizes c&#8208;Myc through direct interaction in the nucleus</text>
    </passage>
    <passage>
      <infon key="volume">442</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">1007</infon>
      <infon key="pub-id_pmid">16929305</infon>
      <infon key="fpage">1003</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>54793</offset>
      <text>Karyopherin&#8208;mediated import of integral inner nuclear membrane proteins</text>
    </passage>
    <passage>
      <infon key="volume">110</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">3130</infon>
      <infon key="pub-id_pmid">23382180</infon>
      <infon key="fpage">3125</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>54867</offset>
      <text>RNA&#8208;binding protein Sam68 controls synapse number and local beta&#8208;actin mRNA metabolism in dendrites</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="source">Oncogene</infon>
      <infon key="lpage">6162</infon>
      <infon key="pub-id_pmid">10557107</infon>
      <infon key="fpage">6158</infon>
      <infon key="year">1999</infon>
      <infon key="type">ref</infon>
      <offset>54971</offset>
      <text>Diverse functions of JNK signaling and c&#8208;Jun in stress response and apoptosis</text>
    </passage>
    <passage>
      <infon key="volume">63</infon>
      <infon key="source">Cancer Res</infon>
      <infon key="lpage">4532</infon>
      <infon key="pub-id_pmid">12907627</infon>
      <infon key="fpage">4527</infon>
      <infon key="year">2003</infon>
      <infon key="type">ref</infon>
      <offset>55051</offset>
      <text>Transcription factor c&#8208;Jun activation represses mdr&#8208;1 gene expression</text>
    </passage>
    <passage>
      <infon key="volume">81</infon>
      <infon key="source">Cell</infon>
      <infon key="lpage">1157</infon>
      <infon key="pub-id_pmid">7600582</infon>
      <infon key="fpage">1147</infon>
      <infon key="year">1995</infon>
      <infon key="type">ref</infon>
      <offset>55125</offset>
      <text>Selective activation of the JNK signaling cascade and c&#8208;Jun transcriptional activity by the small GTPases Rac and Cdc42Hs</text>
    </passage>
    <passage>
      <infon key="volume">83</infon>
      <infon key="source">J Neurosci Res</infon>
      <infon key="lpage">918</infon>
      <infon key="pub-id_pmid">16477618</infon>
      <infon key="fpage">907</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>55249</offset>
      <text>Pro&#8208;apoptotic role of c&#8208;Jun in NMDA&#8208;induced neurotoxicity in the rat retina</text>
    </passage>
    <passage>
      <infon key="volume">327</infon>
      <infon key="source">Biochem Biophys Res Commun</infon>
      <infon key="lpage">191</infon>
      <infon key="pub-id_pmid">15629447</infon>
      <infon key="fpage">183</infon>
      <infon key="year">2005</infon>
      <infon key="type">ref</infon>
      <offset>55331</offset>
      <text>Proteomic analysis revealed a novel synaptic proline&#8208;rich membrane protein (PRR7) associated with PSD&#8208;95 and NMDA receptor</text>
    </passage>
    <passage>
      <infon key="volume">275</infon>
      <infon key="source">Science</infon>
      <infon key="lpage">402</infon>
      <infon key="pub-id_pmid">8994040</infon>
      <infon key="fpage">400</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>55458</offset>
      <text>Reduced ubiquitin&#8208;dependent degradation of c&#8208;Jun after phosphorylation by MAP kinases</text>
    </passage>
    <passage>
      <infon key="volume">303</infon>
      <infon key="source">Science</infon>
      <infon key="lpage">1378</infon>
      <infon key="pub-id_pmid">14739463</infon>
      <infon key="fpage">1374</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>55548</offset>
      <text>The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="source">J Neurosci</infon>
      <infon key="lpage">2163</infon>
      <infon key="pub-id_pmid">8601796</infon>
      <infon key="fpage">2157</infon>
      <infon key="year">1996</infon>
      <infon key="type">ref</infon>
      <offset>55613</offset>
      <text>Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD&#8208;95 family of membrane&#8208;associated guanylate kinases</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="source">Neuron</infon>
      <infon key="lpage">325</infon>
      <infon key="pub-id_pmid">10985351</infon>
      <infon key="fpage">313</infon>
      <infon key="year">2000</infon>
      <infon key="type">ref</infon>
      <offset>55761</offset>
      <text>Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor</text>
    </passage>
    <passage>
      <infon key="volume">210</infon>
      <infon key="source">J Exp Med</infon>
      <infon key="lpage">2567</infon>
      <infon key="pub-id_pmid">24166713</infon>
      <infon key="fpage">2553</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>55872</offset>
      <text>Dual leucine zipper kinase is required for excitotoxicity&#8208;induced neuronal degeneration</text>
    </passage>
    <passage>
      <infon key="volume">353</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">674</infon>
      <infon key="pub-id_pmid">1922387</infon>
      <infon key="fpage">670</infon>
      <infon key="year">1991</infon>
      <infon key="type">ref</infon>
      <offset>55962</offset>
      <text>Phosphorylation of c&#8208;jun mediated by MAP kinases</text>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="source">Prog Neurobiol</infon>
      <infon key="lpage">363</infon>
      <infon key="pub-id_pmid">16716487</infon>
      <infon key="fpage">347</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>56013</offset>
      <text>Role of the AP&#8208;1 transcription factor c&#8208;Jun in developing, adult and injured brain</text>
    </passage>
    <passage>
      <infon key="volume">416</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">874</infon>
      <infon key="pub-id_pmid">11976688</infon>
      <infon key="fpage">870</infon>
      <infon key="year">2002</infon>
      <infon key="type">ref</infon>
      <offset>56100</offset>
      <text>AP&#8208;1 functions upstream of CREB to control synaptic plasticity in Drosophila</text>
    </passage>
    <passage>
      <infon key="volume">17</infon>
      <infon key="source">J Neurosci</infon>
      <infon key="lpage">3466</infon>
      <infon key="pub-id_pmid">9133371</infon>
      <infon key="fpage">3455</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>56179</offset>
      <text>Glutamate, but not dopamine, stimulates stress&#8208;activated protein kinase and AP&#8208;1&#8208;mediated transcription in striatal neurons</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="source">Nat Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="fpage">6</infon>
      <infon key="year">2002</infon>
      <offset>56309</offset>
      <text>AP&#8208;1 as a regulator of cell life and death</text>
    </passage>
    <passage>
      <infon key="volume">354</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">496</infon>
      <infon key="pub-id_pmid">1749429</infon>
      <infon key="fpage">494</infon>
      <infon key="year">1991</infon>
      <infon key="type">ref</infon>
      <offset>56354</offset>
      <text>Oncogenic and transcriptional cooperation with Ha&#8208;Ras requires phosphorylation of c&#8208;Jun on serines 63 and 73</text>
    </passage>
    <passage>
      <infon key="volume">202</infon>
      <infon key="source">J Infect Dis</infon>
      <infon key="lpage">426</infon>
      <infon key="pub-id_pmid">20565256</infon>
      <infon key="fpage">416</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>56467</offset>
      <text>Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy</text>
    </passage>
    <passage>
      <infon key="volume">505</infon>
      <infon key="source">Neurosci Lett</infon>
      <infon key="lpage">81</infon>
      <infon key="pub-id_pmid">21996423</infon>
      <infon key="fpage">76</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>56587</offset>
      <text>Caspase&#8208;3 is a target gene of c&#8208;Jun:ATF2 heterodimers during apoptosis induced by activity deprivation in cerebellar granule neurons</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Neuron</infon>
      <infon key="lpage">726</infon>
      <infon key="pub-id_pmid">9581763</infon>
      <infon key="fpage">709</infon>
      <infon key="year">1998</infon>
      <infon key="type">ref</infon>
      <offset>56724</offset>
      <text>Ca2+ influx regulates BDNF transcription by a CREB family transcription factor&#8208;dependent mechanism</text>
    </passage>
    <passage>
      <infon key="volume">55</infon>
      <infon key="source">Cell Mol Life Sci</infon>
      <infon key="lpage">574</infon>
      <infon key="pub-id_pmid">10357227</infon>
      <infon key="fpage">564</infon>
      <infon key="year">1999</infon>
      <infon key="type">ref</infon>
      <offset>56825</offset>
      <text>Activation of immediate early genes and memory formation</text>
    </passage>
    <passage>
      <infon key="source">Cold Spring Harb Perspect Biol</infon>
      <infon key="volume">3</infon>
      <infon key="pub-id_pmid">21555405</infon>
      <infon key="fpage">a005744</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>56882</offset>
      <text>Neuronal activity&#8208;regulated gene transcription in synapse development and cognitive function</text>
    </passage>
    <passage>
      <infon key="volume">101</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">15910</infon>
      <infon key="pub-id_pmid">15505211</infon>
      <infon key="fpage">15905</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>56977</offset>
      <text>EosFP, a fluorescent marker protein with UV&#8208;inducible green&#8208;to&#8208;red fluorescence conversion</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="source">Mol Cell Biol</infon>
      <infon key="lpage">517</infon>
      <infon key="pub-id_pmid">17101801</infon>
      <infon key="fpage">510</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>57074</offset>
      <text>MEKK1 mediates the ubiquitination and degradation of c&#8208;Jun in response to osmotic stress</text>
    </passage>
    <passage>
      <infon key="volume">389</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">870</infon>
      <infon key="pub-id_pmid">9349820</infon>
      <infon key="fpage">865</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>57165</offset>
      <text>Absence of excitotoxicity&#8208;induced apoptosis in the hippocampus of mice lacking the Jnk3 gene</text>
    </passage>
    <passage>
      <infon key="volume">88</infon>
      <infon key="source">J Neurochem</infon>
      <infon key="lpage">768</infon>
      <infon key="pub-id_pmid">14720225</infon>
      <infon key="fpage">759</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>57260</offset>
      <text>Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography&#8208;tandem mass spectrometry</text>
    </passage>
    <passage>
      <infon key="volume">398</infon>
      <infon key="source">Neurosci Lett</infon>
      <infon key="lpage">273</infon>
      <infon key="pub-id_pmid">16448753</infon>
      <infon key="fpage">268</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>57423</offset>
      <text>NMDA receptor/L&#8208;VGCC&#8208;dependent expression and AMPA/KA receptor&#8208;dependent activation of c&#8208;Jun induced by cerebral ischemia in rat hippocampus</text>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="source">Oncogene</infon>
      <infon key="lpage">1844</infon>
      <infon key="pub-id_pmid">21860413</infon>
      <infon key="fpage">1835</infon>
      <infon key="year">2012a</infon>
      <infon key="type">ref</infon>
      <offset>57572</offset>
      <text>Rack1 protects N&#8208;terminal phosphorylated c&#8208;Jun from Fbw7&#8208;mediated degradation</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="source">Nat Methods</infon>
      <infon key="lpage">729</infon>
      <infon key="pub-id_pmid">22581370</infon>
      <infon key="fpage">727</infon>
      <infon key="year">2012b</infon>
      <infon key="type">ref</infon>
      <offset>57656</offset>
      <text>Rational design of true monomeric and bright photoactivatable fluorescent proteins</text>
    </passage>
  </document>
</collection>
